Breaking News

Lilly Sues HHS, HRSA to Implement Expansive 340B Rebate for All Products and Covered Entity Types

Lilly filed a Nov. 14 lawsuit against HHS and HRSA for blocking its proposed 340B rebate model with Kalderos.
Eli Lilly on Thursday sued the federal government to implement a sweeping 340B rebate model that would apply to all [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Lawsuit to Test Trump Administration’s Stance on 340B Rebates

J&J sued HRSA on Nov. 12 for threatening enforcement action that led the drugmaker to withdraw its 340B rebate proposal.
Johnson & Johnson’s (J&J’s) lawsuit challenging the federal government’s opposition to 340B rebates will test whether the Trump administration is [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in Mississippi, West Virginia, Missouri

Key briefs were filed this week in state contract pharmacy litigation in Mississippi, West Virginia and Missouri.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

New CMS Rule Mulls Data Repository for 340B Claims in 2026, But Implementation Challenges Loom

A new CMS final rule outlines a possible data repository for 340B claims starting in 2026.
Federal regulators are exploring a data repository to identify 340B claims to exclude from certain Medicare inflation rebates in 2026 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Breaking News

J&J Sues HRSA for Blocking Controversial 340B Rebate Model

J&J is suing the federal government to implement the drugmaker's controversial 340B rebate proposal.
Johnson & Johnson (J&J) earlier today sued the federal government to establish a 340B rebate model, marking the latest escalation [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Arkansas Officials, Providers Urge Supreme Court to Deny PhRMA’s Appeal to Overturn 340B Contract Pharmacy Access Law

Attorneys for the state of Arkansas and local providers argued the Supreme Court should not take up PhRMA's appeal to overturn a state 340B law.
Arkansas state officials and providers are urging the U.S. Supreme Court not to take up a drug industry trade group’s [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

State Contract Pharmacy Lawsuit Weekly Roundup: Updates in West Virginia, Missouri, Kansas

Key briefs were filed this week in state contract pharmacy litigation in West Virginia, Missouri and Kansas.
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Major GPO Sues HRSA over Restrictions on How 340B Hospitals Purchase Initial Drug Inventory

Premier, a major GPO, has sued HRSA over a policy restricting how hospitals can purchase initial physical drug inventory.
A major group purchasing organization (GPO) is suing the federal government over a policy that it claims unlawfully restricts how [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Lilly Backs Sanofi Lawsuit Seeking HRSA 340B Records, Argues Contract Pharmacy Agreements Violate 340B Statute

Eli Lilly has filed an amicus brief in support of Sanofi's lawsuit seeking 340B contract pharmacy agreements from HRSA.
Eli Lilly is backing Sanofi’s lawsuit to compel the federal government to release all 340B contract pharmacy agreements, arguing that [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

BI Tightens Contract Pharmacy Restrictions for All Covered Entities

Boehringer Ingelheim recently announced it will tighten its 340B contract pharmacy restrictions by requiring claims data submission.
Drugmaker Boehringer Ingelheim (BI) will begin requiring all 340B covered entities to submit claims data to continue accessing 340B drugs [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live